Cite
MLA Citation
Dung Le et al.. “Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).” Journal for immunotherapy of cancer, vol. 3, no. 2, 2015, p. 1. http://access.bl.uk/ark:/81055/vdc_100080441580.0x000108